Detalles de la búsqueda
1.
Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events.
Ann Rheum Dis
; 2024 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38609158
2.
Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohort.
Ann Rheum Dis
; 2024 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38373843
3.
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update.
Ann Rheum Dis
; 83(1): 15-29, 2024 Jan 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37827694
4.
Predictors of renal flares in systemic lupus erythematosus: a post-hoc analysis of four phase III clinical trials of belimumab.
Rheumatology (Oxford)
; 2024 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38216728
5.
Belimumab and antimalarials combined against renal flares in patients treated for extra-renal systemic lupus erythematosus: results from 4 phase III clinical trials.
Rheumatology (Oxford)
; 63(2): 338-348, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37228028
6.
Determinants of neuropsychiatric flares in patients with systemic lupus erythematosus: results from five phase III trials of belimumab.
Rheumatology (Oxford)
; 63(3): 798-808, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37228034
7.
Patients with neuropsychiatric involvement systemic lupus erythematosus experience poorer health-related quality of life and more fatigue than systemic lupus erythematosus patients with no neuropsychiatric involvement, irrespective of neuropsychiatric activity.
Rheumatology (Oxford)
; 2024 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38579198
8.
Lupus Low Disease Activity State and organ damage in relation to quality of life in systemic lupus erythematosus: a cohort study with up to 11 years of follow-up.
Rheumatology (Oxford)
; 2024 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38402496
9.
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study.
Rheumatology (Oxford)
; 63(3): 657-664, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37228012
10.
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys.
Rheumatology (Oxford)
; 63(1): 127-139, 2024 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37084267
11.
Characteristics and risk factors of COVID-19 breakthrough infections in Idiopathic Inflammatory Myopathies: Results from the COVAD study.
Rheumatology (Oxford)
; 2024 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38430474
12.
Factors associated with non-adherence to medications in systemic lupus erythematosus: Results from a Swedish survey.
Lupus
; 33(6): 615-628, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38545763
13.
Obesity and tobacco smoking are independently associated with poor patient-reported outcomes in SLE: a cross-sectional study.
Rheumatol Int
; 44(5): 851-861, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38451301
14.
Efficacy of lifestyle interventions in the management of systemic lupus erythematosus: a systematic review of the literature.
Rheumatol Int
; 44(5): 765-778, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38451302
15.
COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group.
Rheumatol Int
; 44(1): 73-80, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38060005
16.
Correlates of breakthrough COVID-19 in vaccinated patients with systemic sclerosis: survival analysis from a multicentre international patient-reported survey.
Rheumatol Int
; 44(1): 89-97, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37668836
17.
Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies.
Rheumatol Int
; 2024 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38609655
18.
Molecular architecture of proliferative lupus nephritis as elucidated using 50-plex imaging mass cytometry proteomics.
Clin Immunol
; 254: 109713, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37516396
19.
EULAR recommendations for the non-pharmacological management of systemic lupus erythematosus and systemic sclerosis.
Ann Rheum Dis
; 2023 Aug 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37433575
20.
Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus.
J Autoimmun
; 136: 103025, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36996699